Concepedia

Kunal Desai

KD

7

Publications

259

Citations

7

H-Index

2009

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

IRBM Science Park

Kunal Desai is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2009–2021

7

Publications

7

The Antiobesity Effects of Centrally Administered Neuromedin U and Neuromedin S Are Mediated Predominantly by the Neuromedin U Receptor 2 (NMUR2)

Andrea Peier, Jennifer Kosinski, Kimberly Cox‐York et al. · Endocrinology · 2009 · 77 citations · Full text

, , +17

Effects of Peripherally Administered Neuromedin U on Energy and Glucose Homeostasis

Andrea Peier, Kunal Desai, James Hubert et al. · Endocrinology · 2011 · 63 citations · Full text

, , +19

PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes

Paolo Ingallinella, Andrea Peier, Alessandro Pocai et al. · Bioorganic & Medicinal Chemistry · 2012 · 41 citations

, , +9

Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide

Philippe Neuner, Andrea Peier, Fabio Talamo et al. · Journal of Peptide Science · 2013 · 29 citations

Statin-Induced Autoimmune Necrotizing Myopathy

Sahani Jayatilaka, Kunal Desai, Swarup Sharma Rijal et al. · Journal of Primary Care & Community Health · 2021 · 17 citations · Full text

, , +15

Rows per page

1–5 of 7